Abstract:599 Background: Accurate identification of pCR to neoadjuvant chemotherapy (NAC) is important for determining appropriate surgery strategy and guiding the resection extent in breast cancer. However, a non-invasive tool to predict pCR accurately is lacking. Our study aims to develop ensemble learning models using longitudinal multiparametric MRI to predict pCR for each molecular subtype of breast cancer. Methods: In this study, all patients underwent pre-NAC and post-NAC MRI examinations, and we collected multiparametric MRI sequences. Post-operation pathologic results were used to determine the pathologic complete response (pCR). We extracted 14676 radiomics and 4096 deep learning features and calculated a set of additional delta-value features. Then in the primary cohort (n = 409), inter-class correlation coefficient test, U-test, Boruta and the least absolute shrinkage and selection operator (LASSO) regression were used to select the most optimal feature set for each subtype of breast cancer. Finally, 20, 15 and 13 features were selected to construct the models based on 5 specific algorithms with cross-validation method for predicting pCR in HR+/HER2-, HER2+ and TNBC subtypes. The ensemble learning strategy was used to integrate the single-modality models outputs and improve the prediction performance. The diagnostic performances of models were evaluated in the three external cohorts with lager sample size of patients (n = 343, 170 and 340, respectively). Results: A total of 1262 patients with breast cancer from four centers were enrolled in this study, and pCR rates were 10.6% (52/491), 54.3% (323/595) and 37.5% (66/176) in HR+/HER2-, HER2+ and TNBC subtype. After model development, the Multi-Layer Perception (MLP) neural network yields the best diagnostic performances in all subtypes and feature sets. In the three subtypes, the stacking model integrating pre-, post- and delta- models yielded the highest AUCs of 0.959, 0.974 and 0.958 in the primary cohort, and AUCs of 0.882-0.908, 0.896-0.929 and 0.837-0.901 in the three external validation cohorts, respectively. In all subtypes, the stacking model had accuracies of 85.0%-88.9%, sensitivities of 80.0%-86.3%, and specificities of 87.4%-91.5% in the external validation cohorts. Conclusions: Our study established a novel tool to predict the responses of breast cancer to NAC and achieve excellent performance. The models could help to determine post-NAC surgery strategy for patients with breast cancer.

Deep Learning-Based Segmentation of Locally Advanced Breast Cancer on MRI in Relation to Residual Cancer Burden: A Multi-Institutional Cohort Study

Deep Learning-Based Automatic Segmentation for Size and Volumetric Measurement of Breast Cancer on Magnetic Resonance Imaging.

Assessing Breast Cancer Volume Alterations Post-Neoadjuvant Chemotherapy Through DenseNet-201 Deep Learning Analysis on DCE-MRI

Deep learning-based prediction of response to HER2-targeted neoadjuvant chemotherapy from pre-treatment dynamic breast MRI: A multi-institutional validation study

Monitoring response to neoadjuvant therapy for breast cancer in all treatment phases using an ultrasound deep learning model

Deep learning radiomic analysis of DCE-MRI combined with clinical characteristics predicts pathological complete response to neoadjuvant chemotherapy in breast cancer

Response monitoring of breast cancer on DCE-MRI using convolutional neural network-generated seed points and constrained volume growing

Fully Automated Identification of Lymph Node Metastases and Lymphovascular Invasion in Endometrial Cancer From Multi‐Parametric MRI by Deep Learning

Deep Learning Segmentation of Infiltrative and Enhancing Cellular Tumor on Pre- and Posttreatment Multishell Diffusion MRI of Glioblastoma

MRI‐Based Breast Cancer Classification and Localization by Multiparametric Feature Extraction and Combination Using Deep Learning

Prior to Initiation of Chemotherapy, Can We Predict Breast Tumor Response? Deep Learning Convolutional Neural Networks Approach Using a Breast MRI Tumor Dataset

Radiologist-level Performance by Using Deep Learning for Segmentation of Breast Cancers on MRI Scans

3D Breast Cancer Segmentation in DCE-MRI Using Deep Learning With Weak Annotation

Longitudinal MRI-based fusion novel model to predict pathological complete response in breast cancer treated with neoadjuvant chemotherapy: A multicenter, retrospective study.

Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study

Development and Validation of a Deep Learning System to Differentiate HER2‐Zero, HER2‐Low, and HER2‐Positive Breast Cancer Based on Dynamic Contrast‐Enhanced MRI

Time‐Series MR Images Identifying Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using a Deep Learning Approach

Deep learning prediction of pathological complete response, residual cancer burden, and progression-free survival in breast cancer patients

Deep-learning based discrimination of pathologic complete response using MRI in HER2-positive and triple-negative breast cancer

A Deep Learning Radiomics Nomogram to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer: A Two-Center Study

Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer